COMMUNIQUÉS West-GlobeNewswire

Cellectar and Evestia Clinical Announce Partnership to Support Auger-Emitting Radiopharmaceutical Clinical Trial in Triple-Negative Breast Cancer (TNBC)
24/09/2025
Intends to Initiate Phase 1b Clinical Trial in TNBC at Mayo Clinic in Fourth Quarter 2025 FLORHAM PARK, N.J. and LONDON and CHARLOTTESVILLE, Va., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (“ [...]
Er-Kim Enters Commercialization Agreement with Sentynl Therapeutics for Nulibry® (fosdenopterin) and Zokinvy® (lonafarnib), Targeting Ultra-Rare Diseases
24/09/2025
Expanded access will help bring treatments to patients in certain countries within Central and Eastern Europe, the Mediterranean and Eurasia ATHENS, Greece and SOLANA BEACH, Calif., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Er [...]
Tiziana Life Sciences Announces Poster Presentation on Intranasal Foralumab Clinical Trial at the 41st ECTRIMS Congress
24/09/2025
BOSTON, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]
Sparrow Pharmaceuticals Announces $95 Million Series B Financing to Advance Targeted Therapy for Type 2 Diabetes
24/09/2025
Funding supports Phase 2b development of clofutriben, a novel HSD-1 inhibitor, with a focus on cortisol-driven metabolic dysfunction in type 2 diabetes PORTLAND, Ore., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Sparrow [...]
Sapu Nano’s Sapu003 Advances to Human Clinical Testing - Transforming Everolimus Delivery with Full Bioavailability for Breast Cancer Patients
24/09/2025
Sapu003 Designed to Overcome Limitations of Afinitor®, FDA-Approved Oral Everolimus, by Delivering Full Strength of the Drug via Intravenous Injection SAN DIEGO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- via IBN -- Sapu Nano, [...]
Ultrack Systems Inc. (OTC: MJLB) Subsidiary Better Pets Secures Canadian Trademark Registration and Advances U.S. Trademark Application
24/09/2025
TORONTO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Ultrack Systems Inc. (OTC: MJLB) (“Ultrack” or the “Company”), through its wholly owned subsidiary Better Pets (Better Health Sciences for Pets Corp.), is pleased to announce [...]
Akari Therapeutics’ Preclinical Data Demonstrates the Potential of its Novel ADC Spliceosome Modulating Payload, PH1
24/09/2025
Data highlights ability of Akari’s ADC payload, PH1, to suppress the levels of the AR-V7 receptor that is responsible for driving hormone refractory prostate cancer progression No current therapies have proven to be [...]
OneMedNet Expands Into $1.5B Healthcare Data Annotation Market With MedCase
24/09/2025
MINNEAPOLIS, Sept. 24, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leader in AI-powered Real-World Data (RWD), announced a strategic partnership with [...]
Eupraxia Pharmaceuticals Announces Closing of US$80.5 Million Public Offering Including Full Exercise of Underwriter Option
24/09/2025
VICTORIA, British Columbia, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary [...]
Alira Health Becomes First Platinum CRO Partner of the Wound Care Collaborative Community, Expanding Ongoing Work to Advance Wound Healing Innovation
24/09/2025
FRAMINGHAM, Mass., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Alira Health announced today that it has become the first Platinum CRO Partner of the Wound Care Collaborative Community (WCCC), demonstrating its continued [...]
WORK Medical Technology Group LTD Partners with Hong Kong Web3.0 Standardization Association to Collaborate on Blockchain and RWA Innovations
24/09/2025
Hangzhou, China, Sept. 24, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) [...]
Berry Street Earns Recognition from the American Diabetes Association
24/09/2025
The ADA’s Education Recognition Program certification ensures quality diabetes education and support for people living with diabetes. NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Today, the American Diabetes Association [...]
TOMI Environmental Solutions Announces Specialized Service Provider for Healthcare and Mold Remediation
24/09/2025
FREDERICK, Md., Sept. 24, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced a new service [...]
ITM and TerThera Sign Supply Agreement for Medical Radioisotope Terbium-161
24/09/2025
Garching / Munich, Germany, and Breda, the Netherlands, September 24, 2025 – ITM Isotope Technologies Munich SE (ITM) , a leading radiopharmaceutical biotech company, and TerThera BV , a leading provider of GMP-grade [...]
Artios Receives U.S. FDA Fast Track Designation for alnodesertib in ATM-negative Metastatic Colorectal Cancer (mCRC)
24/09/2025
U.S. Fast Track designation underscores the strength of the alnodesertib clinical data generated to date and the high degree of unmet need in 3L mCRC CAMBRIDGE, United Kingdom and NEW YORK, September 24, 2025 – Artios [...]
Palvella Therapeutics Announces Expansion of QTORIN™ Rapamycin’s Development into Clinically Significant Angiokeratomas, a Rare, Chronically Debilitating Lymphatic Disease with No FDA-approved Therapies
24/09/2025
Clinically significant angiokeratomas are characterized by lymphatic-derived skin lesions that can persistently bleed and significantly impact quality-of-life; no FDA-approved therapies exist for the estimated more than [...]
Communiqué de presse : Mise en ligne du document "Q3 2025 Aide mémoire"
24/09/2025
Mise en ligne du document «Q3 2025 Aide mémoire » Paris, France, le 24 septembre 2025 . Sanofi annonce la mise en ligne sur l'espace Investisseurs du site internet de la société, d'un document intitulé « Q3 2025 Aide [...]
Press release: Availability of the Q3 2025 Aide mémoire
24/09/2025
Availability of the Q3 2025 Aide mémoire Paris, France – September 24, 2025 . Sanofi announced today that its Q3 2025 Aide mémoire is available on the "Investors" page of the company's website: Third quarter 2025 ( [...]
Dimora PHMB Skin and Wound Cleanser - Gentle for Kids, Trusted by Parents
24/09/2025
Dimora PHMB Skin and Wound Cleanser: Gentle for Kids, Trusted by Parents SAN FRANCISCO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Dimora Medical is proud to introduce its newest innovation, the Dimora PHMB Skin and Wound [...]

Pages